Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

J&J Consumer Sales To Feel $650 Mil. Accounting Change Impact In 2002

This article was originally published in The Tan Sheet

Executive Summary

Accounting changes related to slotting fees, sales promotional costs and couponing will reduce Johnson & Johnson's reported consumer sales by $650 mil. in 2002, the firm said during an Oct. 16 analysts call.

You may also be interested in...



FTC Slotting Fee Report Outlines Research Needs, Enforcement Direction

Immediate establishment of formal slotting allowance guidelines is discouraged by the staff of the Federal Trade Commission in a report issued Feb. 20.

Coupon Accounting Adjustment Revenue Impact Cited To Analysts

Pharmaceutical and consumer product firms are beginning to report the financial effects of accounting procedures that change the way some companies account for coupons, rebates and other incentives in income statements.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS093174

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel